Lynne Bemis

8.9k total citations · 2 hit papers
79 papers, 5.7k citations indexed

About

Lynne Bemis is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Lynne Bemis has authored 79 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 28 papers in Cancer Research and 16 papers in Oncology. Recurrent topics in Lynne Bemis's work include MicroRNA in disease regulation (17 papers), Cancer-related molecular mechanisms research (10 papers) and Lung Cancer Treatments and Mutations (9 papers). Lynne Bemis is often cited by papers focused on MicroRNA in disease regulation (17 papers), Cancer-related molecular mechanisms research (10 papers) and Lung Cancer Treatments and Mutations (9 papers). Lynne Bemis collaborates with scholars based in United States, Japan and Bolivia. Lynne Bemis's co-authors include Cecilia Lässer, Jan Lötvall, Marca H. M. Wauben, Johan Skog, Clotilde Théry, Sarada Sivaraman, Fred H. Hochberg, Edit I. Buzás, Kenneth W. Witwer and Adriana Bora and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Lynne Bemis

79 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Standardization of sample collection, isolation and analysis methods in extracellular vesicle research

2013 1.9k citations Lynne Bemis et al. profile →
The multiMiR R package and database: integration of microRNA–target interactions along with their disease and drug associations

2014 475 citations Lynne Bemis et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lynne Bemis United States	32	4.2k	2.5k	916	779	483	79	5.7k
Lars Holmgren Sweden	42	4.7k 1.1×	2.3k 0.9×	1.5k 1.6×	547 0.7×	908 1.9×	77	7.6k
Robert Folberg United States	46	3.8k 0.9×	1.4k 0.6×	2.4k 2.6×	705 0.9×	800 1.7×	191	8.8k
Jeffrey L. Franklin United States	33	5.9k 1.4×	3.2k 1.3×	799 0.9×	289 0.4×	912 1.9×	66	7.0k
James N. Higginbotham United States	26	4.8k 1.1×	2.6k 1.1×	719 0.8×	245 0.3×	788 1.6×	48	5.8k
Colin C. Pritchard United States	22	4.1k 1.0×	3.6k 1.5×	1.2k 1.3×	716 0.9×	352 0.7×	41	6.1k
Amy P.N. Skubitz United States	49	2.7k 0.6×	1.2k 0.5×	1.6k 1.8×	793 1.0×	1.1k 2.3×	134	6.6k
Aadel A. Chaudhuri United States	25	3.4k 0.8×	3.7k 1.5×	794 0.9×	745 1.0×	1.5k 3.2×	89	6.1k
Orla Sheils Ireland	36	2.1k 0.5×	1.4k 0.6×	817 0.9×	376 0.5×	370 0.8×	115	4.1k
Tom Würdinger Netherlands	17	4.7k 1.1×	3.0k 1.2×	615 0.7×	342 0.4×	577 1.2×	33	5.8k
Heather H. Cheng United States	26	2.9k 0.7×	2.5k 1.0×	841 0.9×	1.4k 1.8×	238 0.5×	139	4.7k

Countries citing papers authored by Lynne Bemis

Since Specialization

Citations

This map shows the geographic impact of Lynne Bemis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynne Bemis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynne Bemis more than expected).

Fields of papers citing papers by Lynne Bemis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynne Bemis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynne Bemis. The network helps show where Lynne Bemis may publish in the future.

Co-authorship network of co-authors of Lynne Bemis

This figure shows the co-authorship network connecting the top 25 collaborators of Lynne Bemis. A scholar is included among the top collaborators of Lynne Bemis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynne Bemis. Lynne Bemis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Spillman, Monique A., Kian Behbakht, Juan E. Abrahante, et al.. (2017). A method for extracting and characterizing RNA from urine: For downstream PCR and RNAseq analysis. Analytical Biochemistry. 536. 8–15. 7 indexed citations

Hellwinkel, Justin E., Helen J. Madsen, Tessa Harland, et al.. (2016). HSP90 inhibitors in the context of heat shock and the unfolded protein response: effects on a primary canine pulmonary adenocarcinoma cell line*. International Journal of Hyperthermia. 33(3). 303–317. 10 indexed citations

Clarke, Benjamin L., et al.. (2016). A method to distinguish morphologically similar Peromyscus species using extracellular RNA and high-resolution melt analysis. Analytical Biochemistry. 508. 65–72. 4 indexed citations

Regal, Jean F., et al.. (2016). Role of IgM and angiotensin II Type I receptor autoantibodies in local complement activation in placental ischemia-induced hypertension in the rat. Molecular Immunology. 78. 38–47. 22 indexed citations

Bouma, Gerrit J., et al.. (2014). Identification of heat shock protein 10 within the equine embryo, endometrium, and maternal peripheral blood mononuclear cells. Theriogenology. 83(5). 832–839. 8 indexed citations

Arcaroli, John J., Kevin S. Quackenbush, Todd M. Pitts, et al.. (2012). Common PIK3CA Mutants and a Novel 3′ UTR Mutation Are Associated with Increased Sensitivity to Saracatinib. Clinical Cancer Research. 18(9). 2704–2714. 36 indexed citations

Macy, Margaret E., Diane K. Birks, Valerie N. Barton, et al.. (2012). Clinical and molecular characteristics of congenital glioblastoma. Neuro-Oncology. 14(7). 931–941. 34 indexed citations

Robinson, Steven E., et al.. (2011). Recovery of MicroRNA from Stored Human Peripheral Blood Samples. Biopreservation and Biobanking. 9(1). 29–33. 5 indexed citations

Deng, Yu, Hui Deng, Feng Bi, et al.. (2011). MicroRNA-137 Targets Carboxyl-terminal Binding Protein 1 in Melanoma Cell Lines. International Journal of Biological Sciences. 7(1). 133–137. 57 indexed citations

10.

Helfrich, Barbara A., et al.. (2009). Abstract #4775: The selective aurora B kinase inhibitor AZD1152-HQPA inhibits in vitro growth of small cell lung cancer (SCLC) cell lines. Cancer Research. 69. 4775–4775. 1 indexed citations

11.

Franklin, Wilbur A., Jerry Haney, Michio Sugita, et al.. (2009). KRAS Mutation. Journal of Molecular Diagnostics. 12(1). 43–50. 92 indexed citations

12.

Flaig, Thomas W., Lih‐Jen Su, Caroline E. McCoach, et al.. (2009). Dual epidermal growth factor receptor and vascular endothelial growth factor receptor inhibition with vandetanib sensitizes bladder cancer cells to cisplatin in a dose‐ and sequence‐dependent manner. British Journal of Urology. 103(12). 1729–1737. 25 indexed citations

13.

Weiss, Glen J., Lynne Bemis, Eri Nakajima, et al.. (2008). EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines. Annals of Oncology. 19(6). 1053–1059. 193 indexed citations

14.

Moore, Lorna G., Mark D. Shriver, Lynne Bemis, & Enrique Vargas. (2007). An Evolutionary Model for Identifying Genetic Adaptation to High Altitude. Advances in experimental medicine and biology. 588. 101–118. 13 indexed citations

15.

Hirsch, Fred R., Marileila Varella‐Garcia, Federico Cappuzzo, et al.. (2007). Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib. Annals of Oncology. 18(4). 752–760. 231 indexed citations

16.

Burhansstipanov, Linda, et al.. (2005). Sample Genetic Policy Language for Research Conducted With Native Communities. Journal of Cancer Education. 20(1 Suppl). 52–57. 11 indexed citations

17.

Bemis, Lynne, Denise A. Chan, Carla V. Finkielstein, et al.. (2004). Distinct aerobic and hypoxic mechanisms of HIF-α regulation by CSN5. Genes & Development. 18(7). 739–744. 60 indexed citations

18.

Moore, Lorna G., Mark D. Shriver, Lynne Bemis, et al.. (2004). Maternal Adaptation to High-altitude Pregnancy: An Experiment of Nature—A Review. Placenta. 25. S60–S71. 164 indexed citations

19.

Burhansstipanov, Linda, Lynne Bemis, & Mark Dignan. (2001). Native American cancer education: genetic and cultural issues.. PubMed. 16(3). 142–5. 11 indexed citations

20.

Bemis, Lynne, F. Jon Geske, & Robert Strange. (1995). Chapter 8 Use of the Yeast Two-Hybrid System for Identifying the Cascade of Protein Interactions Resulting in Apoptotic Cell Death. Methods in cell biology. 46. 139–151. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact